These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8399951)

  • 1. Numerical and functional modifications in platelets induced by polyester coated by a hydrophilic polymer.
    Cenni E; Cavedagna D; Falsone G; Mari G; Pizzoferrato A
    Biomaterials; 1993 Jul; 14(8):588-90. PubMed ID: 8399951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet half-life in comparison to other in-vivo platelet function parameters such as thromboxane B2, beta-thromboglobulin and platelet factor 4 in patients with atherosclerotic lesions with and without hyperlipoproteinemia.
    Strobl-Jäger E; Fitscha P; Kaliman J; Widhalm K; Sinzinger H
    Vasa; 1986; 15(4):373-8. PubMed ID: 2948337
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in platelet function in patients with arterial hypertension].
    Malý J; Pecka M; Pintérová E; Pidrman V; Bláha M; Siroký O; Jebavý L
    Vnitr Lek; 1995 Jul; 41(7):458-61. PubMed ID: 7571480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet and coagulation factor variations induced in vitro by polyethylene terephthalate (Dacron) coated with pyrolytic carbon.
    Cenni E; Arciola CR; Ciapetti G; Granchi D; Savarino L; Stea S; Cavedagna D; Curti T; Falsone G; Pizzoferrato A
    Biomaterials; 1995 Sep; 16(13):973-6. PubMed ID: 8580259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of the thromboresistance of Dacron combined with various polyurethanes.
    Leake DL; Cenni E; Cavedagna D; Stea S; Ciapetti G; Pizzoferrato A
    Biomaterials; 1989 Sep; 10(7):441-4. PubMed ID: 2529915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood platelets in cardiopulmonary bypass operations. Recovery occurs after initial stimulation, rather than continual activation.
    Zilla P; Fasol R; Groscurth P; Klepetko W; Reichenspurner H; Wolner E
    J Thorac Cardiovasc Surg; 1989 Mar; 97(3):379-88. PubMed ID: 2918735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Storage of single-donor platelet concentrates: metabolic and functional changes.
    Böck M; Glaser A; Pfosser A; Schleuning M; Heim MU; Mempel W
    Transfusion; 1993 Apr; 33(4):311-5. PubMed ID: 8480351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired in vivo platelet reactivity in infantile autism.
    Safai-Kutti S; Kutti J; Gillberg C
    Acta Paediatr Scand; 1985 Sep; 74(5):799-800. PubMed ID: 2931944
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet activation during steady state sickle cell disease.
    Westwick J; Watson-Williams EJ; Krishnamurthi S; Marks G; Ellis V; Scully MF; White JM; Kakkar VV
    J Med; 1983; 14(1):17-36. PubMed ID: 6224876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal and maternal platelets: activation at time of birth.
    Suarez CR; Gonzalez J; Menendez C; Fareed J; Fresco R; Walenga J
    Am J Hematol; 1988 Sep; 29(1):18-21. PubMed ID: 2972197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
    Ding YA; Chou TC; Lin KC
    J Hum Hypertens; 1994 Apr; 8(4):273-8. PubMed ID: 8021907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of labetalol on human platelet function.
    Anfossi G; Trovati M; Lanzio M; Mularoni E; Massucco P; Emanuelli G
    Clin Exp Pharmacol Physiol; 1988 Jun; 15(6):437-48. PubMed ID: 2856060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of prostacyclin during cardiopulmonary bypass in men on plasma levels of beta-thromboglobulin, platelet factor 4, thromboxane B2, 6-keto-prostaglandin F1 alpha and heparin.
    Ditter H; Heinrich D; Matthias FR; Sellmann-Richter R; Wagner WL; Hehrlein FW
    Thromb Res; 1983 Nov; 32(4):393-408. PubMed ID: 6197766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of platelets in patients with chronic proliferative glomerulonephritis and the nephrotic syndrome.
    Tomura S; Ida T; Kuriyama R; Chida Y; Takeuchi J; Motomiya T; Yamazaki H
    Clin Nephrol; 1982 Jan; 17(1):24-30. PubMed ID: 6459902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced platelet release reaction, shortened platelet survival time and increased platelet aggregation and plasma thromboxane B2 in chronic obstructive arterial disease.
    Zahavi J; Zahavi M
    Thromb Haemost; 1985 Feb; 53(1):105-9. PubMed ID: 3158092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigations on platelet function in diabetes mellitus.
    Kubisz P; Arabi A; Holan J; Cronberg S
    Haemostasis; 1984; 14(4):347-53. PubMed ID: 6238882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of platelet reactivity in diabetes mellitus.
    Kutti J; Wadenvik H; Henestam B; Stenström G
    Acta Med Scand; 1986; 219(2):195-9. PubMed ID: 2938425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of platelet function in patients with Raynaud's syndrome.
    Hutton RA; Mikhailidis DP; Bernstein RM; Jeremy JY; Hughes GR; Dandona P
    J Clin Pathol; 1984 Feb; 37(2):182-7. PubMed ID: 6229551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation and problems on platelet function tests].
    Kume S
    Nihon Rinsho; 1997 Mar; 55 Suppl 1():94-101. PubMed ID: 9097565
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhanced platelet release reaction and increased thromboxane generation in esophageal achalasia and selective in vitro inhibition of arachidonic acid induced platelet aggregation by vasoactive intestinal peptide.
    Zahavi M; Rozen P; Zahavi J
    Thromb Res; 1990 Aug; 59(3):693-9. PubMed ID: 2146767
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.